Wolf Elmar, Lin Charles Y, Eilers Martin, Levens David L
Theodor Boveri Institute, Biocenter, and Comprehensive Cancer Center, University of Würzburg, Am Hubland, 97074 Würzburg, Germany.
Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
Trends Cell Biol. 2015 Apr;25(4):241-8. doi: 10.1016/j.tcb.2014.10.006. Epub 2014 Dec 1.
Myc deregulation is a hallmark oncogenic event where overexpression of the transcription factor gives rise to numerous tumorigenic phenotypes. The complex consequences of Myc deregulation have prevented clear mechanistic interpretations of its function. A synthesis of recent experimental observations offers a consensus on the direct transcriptional function of Myc: when overexpressed, Myc broadly engages the established euchromatic cis-regulatory landscape of the cell, where the factor generally amplifies transcription. The level of Myc binding at target genes and the transcriptional output are differentially modulated by additional regulators, including Miz1. Targeting Myc oncogenic activity will require an understanding of whether amplification promotes tumorigenesis and the consequences of amplification in tumors adapted to oncogenic Myc.
Myc失调是一种标志性的致癌事件,转录因子的过表达会引发众多致瘤表型。Myc失调的复杂后果阻碍了对其功能的清晰机制解释。对近期实验观察结果的综合分析就Myc的直接转录功能达成了共识:当过表达时,Myc广泛作用于细胞既定的常染色质顺式调控格局,该因子通常会增强转录。包括Miz1在内的其他调节因子会对Myc在靶基因上的结合水平和转录输出进行差异调节。靶向Myc致癌活性将需要了解扩增是否促进肿瘤发生以及在适应致癌性Myc的肿瘤中扩增的后果。